{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:18:27Z","timestamp":1792081107420,"version":"4.4.0"},"reference-count":30,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"\u201cla Caixa\u201d Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2017,6,7]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To examine the association between chronic immune-mediated diseases (rheumatoid arthritis, systemic lupus erythematosus or the following chronic immune-mediated inflammatory diagnoses groups: inflammatory bowel diseases, inflammatory polyarthropathies, systemic connective tissue disorders and spondylopathies) and the 6-year coronary artery disease, stroke, cardiovascular disease incidence and overall mortality; and to estimate the population attributable fractions for all four end-points for each chronic immune-mediated inflammatory disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cohort study of individuals aged 35\u201385 years, with no history of cardiovascular disease from Catalonia (Spain). The coded diagnoses of chronic immune-mediated diseases and cardiovascular diseases were ascertained and registered using validated codes, and date of death was obtained from administrative data. Cox regression models for each outcome according to exposure were fitted to estimate HRs in two models\n<jats:sup>1<\/jats:sup>\n: after adjustment for sex, age, cardiovascular risk factors and\n<jats:sup>2<\/jats:sup>\n further adjusted for drug use. Population attributable fractions were estimated for each exposure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Data were collected from 991\u2009546 participants. The risk of cardiovascular disease was increased in systemic connective tissue disorders (model 1: HR=1.38 (95% CI 1.21 to 1.57) and model 2: HR=1.31 (95% CI 1.15 to 1.49)), rheumatoid arthritis (HR=1.43 (95% CI 1.26 to 1.62) and HR=1.31 (95% CI 1.15 to 1.49)) and inflammatory bowel diseases (HR=1.18 (95% CI 1.06 to 1.32) and HR=1.12 (95% CI 1.01 to 1.25)). The effect of anti-inflammatory treatment was significant in all instances (HR=1.50 (95% CI 1.24 to 1.81); HR=1.47 (95% CI 1.23 to 1.75); HR=1.43 (95% CI 1.19 to 1.73), respectively). The population attributable fractions for all three disorders were 13.4%, 15.7% and 10.7%, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Systemic connective tissue disorders and rheumatoid arthritis conferred the highest cardiovascular risk and population impact, followed by inflammatory bowel diseases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2017-311279","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T20:10:31Z","timestamp":1503951031000},"page":"119-126","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":91,"title":["Association between chronic immune-mediated inflammatory diseases and cardiovascular risk"],"prefix":"10.1136","volume":"104","author":[{"given":"Jose Miguel","family":"Baena-D\u00edez","sequence":"first","affiliation":[{"name":"Cardiovascular Epidemiology and Genetics Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"La Marina Primary Care Centre and Primary Care Research Institute Jordi Gol, Catalan Institute of Health, Barcelona, Spain"},{"name":"Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Garcia-Gil","sequence":"additional","affiliation":[{"name":"Primary Care Research Institute Jordi Gol, Girona, Spain"},{"name":"Research Unit in Primary Care, Primary Care Services Girona, Catalan Institute of Health (ICS), Girona, Spain"},{"name":"Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Comas-Cuf\u00ed","sequence":"additional","affiliation":[{"name":"Primary Care Research Institute Jordi Gol, Girona, Spain"},{"name":"Research Unit in Primary Care, Primary Care Services Girona, Catalan Institute of Health (ICS), Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafel","family":"Ramos","sequence":"additional","affiliation":[{"name":"Primary Care Research Institute Jordi Gol, Girona, Spain"},{"name":"Research Unit in Primary Care, Primary Care Services Girona, Catalan Institute of Health (ICS), Girona, Spain"},{"name":"Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain"},{"name":"Biomedical Research Institute, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Prieto-Alhambra","sequence":"additional","affiliation":[{"name":"Musculoskeletal Diseases Research Group (GREMPAL), Primary Care Research Institute Jordi Gol, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Musculoskeletal Pharmaco- and Device Epidemiology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betlem","family":"Salvador-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Cardiovascular Epidemiology and Genetics Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"Florida Sud Primary Care Centre and Primary Care Research Institute Jordi Gol, Catalan Institute of Health, L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Elosua","sequence":"additional","affiliation":[{"name":"Cardiovascular Epidemiology and Genetics Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene R","family":"D\u00e9gano","sequence":"additional","affiliation":[{"name":"Cardiovascular Epidemiology and Genetics Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Pe\u00f1afiel","sequence":"additional","affiliation":[{"name":"Cardiovascular Epidemiology and Genetics Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2807-8136","authenticated-orcid":false,"given":"Mar\u00eda","family":"Grau","sequence":"additional","affiliation":[{"name":"Cardiovascular Epidemiology and Genetics Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,8,28]]},"reference":[{"key":"2025100702215604000_104.2.119.1","unstructured":"World Health Statistics [Homepage on the internet]. Geneva: World Health Organization. 2013 https:\/\/apps.who.int\/infobase\/ (Cited 27 Nov 2015)."},{"key":"2025100702215604000_104.2.119.2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12406"},{"key":"2025100702215604000_104.2.119.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu403"},{"key":"2025100702215604000_104.2.119.4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.63"},{"key":"2025100702215604000_104.2.119.5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"2025100702215604000_104.2.119.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.22568"},{"key":"2025100702215604000_104.2.119.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202007"},{"key":"2025100702215604000_104.2.119.8","first-page":"612","article-title":"Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Papagoras","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2025100702215604000_104.2.119.9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.recesp.2011.07.017","article-title":"Validity for use in research on vascular diseases of the SIDIAP (Information System for the Development of Research in Primary Care): the EMMA study","volume":"65","author":"Ramos","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"2025100702215604000_104.2.119.10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10067-014-2801-1","article-title":"The descriptive epidemiology of rheumatoid arthritis in Catalonia: a retrospective study using routinely collected data","volume":"35","author":"Fina-Aviles","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2025100702215604000_104.2.119.11","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2217"},{"key":"2025100702215604000_104.2.119.12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204573"},{"key":"2025100702215604000_104.2.119.13","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.168"},{"key":"2025100702215604000_104.2.119.14","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.727"},{"key":"2025100702215604000_104.2.119.15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070367"},{"key":"2025100702215604000_104.2.119.16","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2005.038505"},{"key":"2025100702215604000_104.2.119.17","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"2025100702215604000_104.2.119.18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.009990"},{"key":"2025100702215604000_104.2.119.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.07.010"},{"key":"2025100702215604000_104.2.119.20","first-page":"1717","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2017","journal-title":"Eur Heart J"},{"key":"2025100702215604000_104.2.119.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.12.002"},{"key":"2025100702215604000_104.2.119.22","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21187"},{"key":"2025100702215604000_104.2.119.23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303285"},{"key":"2025100702215604000_104.2.119.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.06.004"},{"key":"2025100702215604000_104.2.119.25","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes353"},{"key":"2025100702215604000_104.2.119.26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"del Rinc\u00f3n","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025100702215604000_104.2.119.27","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308953"},{"key":"2025100702215604000_104.2.119.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113696"},{"key":"2025100702215604000_104.2.119.29","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.117200"},{"key":"2025100702215604000_104.2.119.30","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/art.39195","article-title":"Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-311279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:22:10Z","timestamp":1759828930000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-311279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,28]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,3]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/heartjnl-2017-311279"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-311279","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,28]]}}}